Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers?

Biological Psychiatry
Heinz SteinerMichela Marinelli

Abstract

There is growing use of psychostimulant cognitive enhancers such as methylphenidate (Ritalin). Methylphenidate differs from the psychostimulant cocaine because it does not enhance synaptic levels of serotonin. We investigated whether exposure to methylphenidate combined with a serotonin-enhancing medication, the prototypical selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac), would produce more "cocaine-like" molecular and behavioral changes. We measured the effects of fluoxetine on gene expression induced by the cognitive enhancer methylphenidate in the striatum and nucleus accumbens of rats, by in situ hybridization histochemistry. We also determined whether fluoxetine modified behavioral effects of methylphenidate. Fluoxetine robustly potentiated methylphenidate-induced expression of the transcription factors c-fos and zif 268 throughout the striatum and to some degree in the nucleus accumbens. Fluoxetine also enhanced methylphenidate-induced stereotypical behavior. Both potentiated gene regulation in the striatum and the behavioral effects indicate that combining the SSRI fluoxetine with the cognitive enhancer methylphenidate mimics cocaine effects, consistent with an increased risk for substance use disorder.

References

Apr 25, 2000·Neuron·J D Berke, S E Hyman
Oct 29, 2000·Trends in Neurosciences·A M GraybielC Capper-Loup
Jan 8, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Motoyo Yano, Heinz Steiner
Apr 30, 2005·Trends in Pharmacological Sciences·Susan L Andersen
Jan 27, 2007·Science·Nasir H NaqviAntoine Bechara
Oct 30, 2007·Trends in Pharmacological Sciences·Motoyo Yano, Heinz Steiner
Jan 5, 2008·Journal of the American Academy of Child and Adolescent Psychiatry·Timothy E WilensSteven Fusillo

❮ Previous
Next ❯

Citations

May 27, 2011·Neuroscience Bulletin·Normand Carrey, Michael Wilkinson
Jul 15, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Brandon L WarrenCarlos A Bolaños-Guzmán
Jan 24, 2014·Psychopharmacology·Lyonna F AlcantaraCarlos A Bolaños-Guzmán
Oct 23, 2012·Progress in Neurobiology·Heinz Steiner, Vincent Van Waes
Jul 28, 2012·Experimental Neurology·Nabila HajiDiego Centonze
Oct 8, 2020·Frontiers in Psychiatry·Flavia NapoletanoAlessandro Vento

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.